140 related articles for article (PubMed ID: 21766489)
1. Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients.
Konjevic G; Radenkovic S; Srdic T; Jurisic V; Stamatovic Lj; Milovic M
J BUON; 2011; 16(2):219-26. PubMed ID: 21766489
[TBL] [Abstract][Full Text] [Related]
2. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.
Mirjačić Martinović K; Srdić-Rajić T; Babović N; Džodić R; Jurišić V; Konjević G
J Clin Pathol; 2016 Apr; 69(4):300-6. PubMed ID: 26442832
[TBL] [Abstract][Full Text] [Related]
4. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
5. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
7. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.
Mirjačić Martinović K; Konjević G; Babović N; Inić M
J Surg Res; 2011 Dec; 171(2):637-49. PubMed ID: 20828749
[TBL] [Abstract][Full Text] [Related]
8. [The roles of soluble MICA in immune escape of breast tumor].
Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
[TBL] [Abstract][Full Text] [Related]
9. [The possibilities of modulation of NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 2002; (47):89-101. PubMed ID: 16078444
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
Konjević G; Spuzić I
J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
[TBL] [Abstract][Full Text] [Related]
11. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
[TBL] [Abstract][Full Text] [Related]
13. Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.
Beitsch P; Lotzová E; Hortobagyi G; Pollock R
Surg Oncol; 1994 Aug; 3(4):211-9. PubMed ID: 7834112
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of natural killer cell activity in pre and post treated breast cancer patients.
Piroozmand A; Hassan ZM
J Cancer Res Ther; 2010; 6(4):478-81. PubMed ID: 21358084
[TBL] [Abstract][Full Text] [Related]
15. Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
[TBL] [Abstract][Full Text] [Related]
16. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.
Santos MF; Mannam VK; Craft BS; Puneky LV; Sheehan NT; Lewis RE; Cruse JM
Exp Mol Pathol; 2014 Jun; 96(3):367-74. PubMed ID: 24731923
[TBL] [Abstract][Full Text] [Related]
18. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.
Ciszak L; Kosmaczewska A; Werynska B; Szteblich A; Jankowska R; Frydecka I
Oncol Rep; 2009 Jan; 21(1):173-84. PubMed ID: 19082459
[TBL] [Abstract][Full Text] [Related]
19. [The effect of serum on NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
[TBL] [Abstract][Full Text] [Related]
20. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
